STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 61 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,829,000 | -54.4% | 1,025,000 | -59.8% | 0.04% | +6.1% |
| Q4 2020 | $6,198,000 | +140.0% | 2,550,568 | +107.4% | 0.03% | -13.2% |
| Q3 2020 | $2,583,000 | -43.7% | 1,230,000 | +1.4% | 0.04% | -52.5% |
| Q2 2020 | $4,585,000 | +72.1% | 1,213,139 | -13.9% | 0.08% | +19.4% |
| Q1 2020 | $2,664,000 | -38.6% | 1,409,419 | -32.1% | 0.07% | -30.9% |
| Q4 2019 | $4,337,000 | +23.0% | 2,075,000 | +40.7% | 0.10% | 0.0% |
| Q3 2019 | $3,525,000 | -10.6% | 1,475,000 | +17.1% | 0.10% | +7.8% |
| Q2 2019 | $3,944,000 | -20.8% | 1,260,000 | +26.0% | 0.09% | +40.6% |
| Q1 2019 | $4,980,000 | +11.2% | 1,000,000 | 0.0% | 0.06% | +6.7% |
| Q4 2018 | $4,480,000 | +36.8% | 1,000,000 | +48.1% | 0.06% | +50.0% |
| Q3 2018 | $3,274,000 | +98.4% | 675,100 | +145.5% | 0.04% | +73.9% |
| Q2 2018 | $1,650,000 | -23.9% | 275,000 | +12.2% | 0.02% | -48.9% |
| Q1 2018 | $2,168,000 | +19.6% | 245,000 | -2.0% | 0.04% | +15.4% |
| Q4 2017 | $1,813,000 | – | 250,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |